Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer

[1] Babjuk M(2011)EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 997-1008

[2] Oosterlinck W(2011)T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy Int Urol Nephrol 43 1047-1057

[3] Sylvester R(2015)Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer Int Urol Nephrol 47 1509-1514

[4] De Berardinis E(2018)Contribution of bladder cancer pathology assessment in planning clinical trials Urol Oncol 90 126-130

[5] Busetto GM(2016)“En bloc” resection of nonmuscle invasive bladder cancer: a prospective single-center study Urology 57 843-849

[6] Antonini G(2010)Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience Eur Urol 24 69-73

[7] Koie T(2018)Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: an update from the National Cancer Data Base (2004–2013) Urol Oncol 25 1599-1603

[8] Ohyama C(2010)Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer J Endourol 29 423-427

[9] Hosogoe S(2011)Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study J Endourol 29 429-432

[10] Guo CC(2011)Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection World J Urol 65 778-792

[1] Babjuk M(2011)EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 997-1008

[2] Oosterlinck W(2011)T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy Int Urol Nephrol 43 1047-1057

[3] Sylvester R(2015)Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer Int Urol Nephrol 47 1509-1514

[4] De Berardinis E(2018)Contribution of bladder cancer pathology assessment in planning clinical trials Urol Oncol 90 126-130

[5] Busetto GM(2016)“En bloc” resection of nonmuscle invasive bladder cancer: a prospective single-center study Urology 57 843-849

[6] Antonini G(2010)Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience Eur Urol 24 69-73

[7] Koie T(2018)Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: an update from the National Cancer Data Base (2004–2013) Urol Oncol 25 1599-1603

[8] Ohyama C(2010)Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer J Endourol 29 423-427

[9] Hosogoe S(2011)Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study J Endourol 29 429-432

[10] Guo CC(2011)Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection World J Urol 65 778-792